The interplay between inflammation and fibrosis in kidney transplantation

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Torres, Irina B ^a   Moreso, Francesc ^a   Sarró, Eduard ^b   Meseguer, Anna ^b   Serón, Daniel ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHEMOKINE; CYCLOSPORIN; CYTOKINE; EVEROLIMUS; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; STEROID; TACROLIMUS; IMMUNOSUPPRESSIVE AGENT;

ACUTE GRAFT REJECTION; DISEASE COURSE; DRUG EFFICACY; GRAFT SURVIVAL; HISTOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; NEPHRITIS; REPERFUSION INJURY; REVIEW; RISK FACTOR; STEROID THERAPY; COMPLICATION; DRUG EFFECTS; FIBROSIS; GRAFT REJECTION; HUMAN; IMMUNOLOGY; INFLAMMATION; PATHOLOGY;

CYCLOSPORINE; FIBROSIS; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; KIDNEY TRANSPLANTATION; TACROLIMUS;

EID: 84903643233     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/750602     Document Type: Review

References (72)

1. Liu Y., Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney International 2006 69 2 213 217 2-s2.0-33644638349 10.1038/sj.ki.5000054 (Pubitemid 43323069)
2. Eddy A. A., Molecular basis of renal fibrosis. Pediatric Nephrology 2000 15 3-4 290 301 2-s2.0-0033638127 10.1007/s004670000461
3. Kisseleva T., Brenner D. A., Mechanisms of fibrogenesis. Experimental Biology and Medicine 2008 233 2 109 122 2-s2.0-38949128021 10.3181/0707-MR-190 (Pubitemid 351231543)
4. Blank U., Essig M., Scandiuzzi L., Benhamou M., Kanamaru Y., Mast cells and inflammatory kidney disease. Immunological Reviews 2007 217 1 79 95 2-s2.0-34248205115 10.1111/j.1600-065X.2007.00503.x (Pubitemid 46718138)
5. Ferguson M. W., O'Kane S., Scar-free healing: from embryonic mechanism to adult therapeutic intervention. Philosophical Transactions of the Royal Society B: Biological Sciences 2004 359 1445 839 850 2-s2.0-2542505844 10.1098/rstb.2004.1475 (Pubitemid 38673751)
6. Martin P., Parkhurst S. M., Parallels between tissue repair and embryo morphogenesis. Development 2004 131 13 3021 3034 2-s2.0-4043109043 10.1242/dev.01253 (Pubitemid 39077428)
7. Kluth D. C., Erwig L.-P., Rees A. J., Multiple facets of macrophages in renal injury. Kidney International 2004 66 2 542 557 2-s2.0-3242776999 10.1111/j.1523-1755.2004.00773.x (Pubitemid 38981994)
8. Wilson H. M., Walbaum D., Rees A. J., Macrophages and the kidney. Current Opinion in Nephrology and Hypertension 2004 13 3 285 290 2-s2.0-2342576796 10.1097/00041552-200405000-00004 (Pubitemid 38582301)
9. Segerer S., Djafarzadeh R., Grone H.-J., Weingart C., Kerjaschki D., Weber C., Kungl A. J., Regele H., Proudfoot A. E. I., Nelson P. J., Selective binding and presentation of CCL5 by discrete tissue microenvironments during renal inflammation. Journal of the American Society of Nephrology 2007 18 6 1835 1844 2-s2.0-34249060155 10.1681/ASN.2006080837 (Pubitemid 46870320)
10. Ferenbach D., Kluth D. C., Hughes J., Inflammatory cells in renal injury and repair. Seminars in Nephrology 2007 27 3 250 259 2-s2.0-34249091068 10.1016/j.semnephrol.2007.02.001 (Pubitemid 46802913)
11. Yang D., Oppenheim J. J., Antimicrobial proteins act as "alarmins" in joint immune defense. Arthritis & Rheumatism 2004 50 11 3401 3403 2-s2.0-8444229353 10.1002/art.20604 (Pubitemid 39488662)
12. Bataller R., Brenner D. A., Liver fibrosis. The Journal of Clinical Investigation 2005 115 2 209 218 2-s2.0-14944385607 10.1172/JCI200524282 (Pubitemid 40385459)
13. Border W. A., Noble N. A., Transforming growth factor β in tissue fibrosis. The New England Journal of Medicine 1994 331 19 1286 1292 2-s2.0-0028109801 10.1056/NEJM199411103311907 (Pubitemid 24333194)
14. Eddy A. A., Progression in chronic kidney disease. Advances in Chronic Kidney Disease 2005 12 4 353 365 2-s2.0-25444441069 10.1053/j.ackd.2005.07.011 (Pubitemid 41376493)
15. Diamond J. R., Pesek-Diamond I., Sublethal X-irradiation during acute puromycin nephrosis prevents late renal injury: role of macrophages. The American Journal of Physiology: Renal Fluid and Electrolyte Physiology 1991 260 6 F779 F786 2-s2.0-0025883784
16. van Goor H., van der Horst M. L. C., Fidler V., Grond J., Glomerular macrophage modulation affects mesangial expansion in the rat after renal ablation. Laboratory Investigation 1992 66 5 564 571 2-s2.0-0026723873
17. Lee S. B., Kalluri R., Mechanistic connection between inflammation and fibrosis. Kidney International Supplement 2010 78 119 S22 S26 2-s2.0-78649669329 10.1038/ki.2010.418
18. Lan H. Y., Diverse roles of TGF- β /Smads in renal fibrosis and inflammation. International Journal of Biological Sciences 2011 7 7 1056 1067 2-s2.0-80052754775
19. Sironi L., Nobili E., Gianella A., Gelosa P., Tremoli E., Anti-inflammatory properties of drugs acting on the renin-angiotensin system. Drugs of Today 2005 41 9 609 622 2-s2.0-29144517417 10.1358/dot.2005.41.9.899613 (Pubitemid 41810476)
20. Ruiz-Ortega M., Ruperez M., Esteban V., Rodríguez-Vita J., Sánchez-López E., Carvajal G., Egido J., Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases. Nephrology Dialysis Transplantation 2006 21 1 16 20 2-s2.0-30344442801 10.1093/ndt/gfi265 (Pubitemid 43057101)
21. Harris R. C., Cheng H.-F., The intrarenal renin-angiotensin system: a paracrine system for the local control of renal function separate from the systemic axis. Experimental Nephrology 1996 4 supplement 1 2 7 2-s2.0-0029731306 (Pubitemid 26421850)
22. Fern R. J., Yesko C. M., Thornhill B. A., Kim H.-S., Smithies O., Chevalier R. L., Reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in mice. The Journal of Clinical Investigation 1999 103 1 39 46 2-s2.0-0032919613 (Pubitemid 29031161)
23. Mezzano S., Aros C., Droguett A., Burgos M. E., Ardiles L., Flores C., Schneider H., Ruiz-Ortega M., Egido J., NF- B activation and overexpression of regulated genes in human diabetic nephropathy. Nephrology Dialysis Transplantation 2004 19 10 2505 2512 2-s2.0-5444272878 10.1093/ndt/gfh207 (Pubitemid 39360096)
24. Park W. D., Griffin M. D., Cornell L. D., Cosio F. G., Stegall M. D., Fibrosis with inflammation at one year predicts transplant functional decline. Journal of the American Society of Nephrology 2010 21 11 1987 1997 2-s2.0-78149307632 10.1681/ASN.2010010049
25. Famulski K. S., Reeve J., De Freitas D. G., Kreepala C., Chang J., Halloran P. F., Kidney transplants with progressing chronic diseases express high levels of acute kidney injury transcripts. American Journal of Transplantation 2013 13 3 634 644 2-s2.0-84874417380 10.1111/ajt.12080
26. Halloran P. F., Pereira A. B., Chang J., Matas A., Picton M., De Freitas D., Bromberg J., Serõn D., Sellarés J., Einecke G., Reeve J., Potential impact of microarray diagnosis of t cell-mediated rejection in kidney transplants: The INTERCOM study. American Journal of Transplantation 2013 13 9 2352 2363 2-s2.0-84883452203 10.1111/ajt.12387
27. Meier-Kriesche H.-U., Schold J. D., Srinivas T. R., Reed A., Kaplan B., Kidney transplantation halts cardiovascular disease progression in patients with end-stage renal disease. American Journal of Transplantation 2004 4 10 1662 1668 2-s2.0-4744366713 10.1111/j.1600-6143.2004.00573.x (Pubitemid 39312301)
28. Cosio F. G., Pelletier R. P., Falkenhain M. E., Henry M. L., Elkhammas E. A., Davies E. A., Bumgardner G. L., Ferguson R. M., Impact of acute rejection and early allograft function on renal allograft survival. Transplantation 1997 63 11 1611 1615 2-s2.0-0031007211 10.1097/00007890-199706150-00013 (Pubitemid 27265503)
29. Schold J. D., Howard R. J., Scicchitano M. J., Meier-Kriesche H.-U., The expanded criteria donor policy: an evaluation of program objectives and indirect ramifications. American Journal of Transplantation 2006 6 7 1689 1695 2-s2.0-33745378855 10.1111/j.1600-6143.2006.01390.x (Pubitemid 43945811)
30. Anglicheau D., Loupy A., Lefaucheur C., Pessione F., Létourneau I., Côté I., Gaha K., Noël L.-H., Patey N., Droz D., Martinez F., Zuber J., Glotz D., Thervet E., Legendre C., A simple clinico- histopathological composite scoring system is highly predictive of graft outcomes in marginal donors. American Journal of Transplantation 2008 8 11 2325 2334 2-s2.0-53749090221 10.1111/j.1600-6143.2008.02394.x
31. Remuzzi G., Cravedi P., Perna A., Dimitrov B. D., Turturro M., Locatelli G., Rigotti P., Baldan N., Beatini M., Valente U., Scalamogna M., Ruggenenti P., Long-term outcome of renal transplantation from older donors. The New England Journal of Medicine 2006 354 4 343 352 2-s2.0-31344460373 10.1056/NEJMoa052891 (Pubitemid 43145059)
32. Nyberg S. L., Matas A. J., Kremers W. K., Thostenson J. D., Larson T. S., Prieto M., Ishitani M. B., Sterioff S., Stegall M. D., Improved scoring system to assess adult donors for cadaver renal transplantation. American Journal of Transplantation 2003 3 6 715 721 2-s2.0-0037531598 10.1034/j.1600-6143.2003. 00111.x (Pubitemid 36745244)
33. Kasiske B. L., Stewart D. E., Bista B. R., The role of procurement biopsies in acceptance decisions for kidneys retrieved for transplant. Clinical Journal of the American Society of Nephrology 2014 9 3 562 571 10.2215/CJN.07610713
34. Azancot M. A., Moreso F., Salcedo M., The reproducibility and predictive value on outcome of renal biopsies from expanded criteria donors. Kidney International 2014 85 5 1161 1168 10.1038/ki.2013.461
35. Sharfuddin A. A., Molitoris B. A., Pathophysiology of ischemic acute kidney injury. Nature Reviews Nephrology 2011 7 4 189 200 2-s2.0-79953175649 10.1038/nrneph.2011.16
36. Perico N., Cattaneo D., Sayegh M. H., Remuzzi G., Delayed graft function in kidney transplantation. The Lancet 2004 364 9447 1814 1827 2-s2.0-8444229815 10.1016/S0140-6736(04)17406-0 (Pubitemid 39488068)
37. Steegh F. M., Gelens M. A., Nieman F. H., van Hooff J. P., Cleutjens J. P. M., van Suylen R. J., Daemen M. J. A. P., van Heurn E. L. W., Christiaans M. H. L., Peutz-Kootstra C. J., Early loss of peritubular capillaries after kidney transplantation. Journal of the American Society of Nephrology 2011 22 6 1024 1029 2-s2.0-79957748397 10.1681/ASN.2010050531
38. Kaminska D., Tyran B., Mazanowska O., Rabczynski J., Szyber P., Patrzalek D., Chudoba P., Polak W. G., Klinger M., Cytokine gene expression in kidney allograft biopsies after donor brain death and ischemia-reperfusion injury using in situ reverse-transcription polymerase chain reaction analysis. Transplantation 2007 84 9 1118 1124 2-s2.0-36248981550 10.1097/01.tp.0000287190. 86654.74 (Pubitemid 350125353)
39. INK4a in deteriorating renal transplants and diseased native kidney. American Journal of Transplantation 2005 5 6 1375 1382 2-s2.0-20544432681 10.1111/j.1600-6143.2005.00846.x (Pubitemid 40839428)
40. Dimeny E., Wahlberg J., Larsson E., Fellstrom B., Can histopathological findings in early renal allograft biopsies identify patients at risk for chronic vascular rejection? Clinical Transplantation 1995 9 2 79 84 2-s2.0-0028965816
41. Seron D., Moreso F., Fulladosa X., Hueso M., Carrera M., Grinyó J. M., Reliability of chronic allograft nephropathy diagnosis in sequential protocol biopsies. Kidney International 2002 61 2 727 733 2-s2.0-0036154097 10.1046/j.1523-1755.2002.00174.x (Pubitemid 34102616)
42. Isoniemi H. M., Krogerus L., von Willebrand E., Taskinen E., Ahonen J., Hayry P., Histopathological findings in well-functioning, long-term renal allografts. Kidney International 1992 41 1 155 160 2-s2.0-0026558834
43. El-Zoghby Z. M., Stegall M. D., Lager D. J., Kremers W. K., Amer H., Gloor J. M., Cosio F. G., Identifying specific causes of kidney allograft loss. American Journal of Transplantation 2009 9 3 527 535 2-s2.0-60649101659 10.1111/j.1600-6143.2008.02519.x
44. Sellares J., de Freitas D. G., Mengel M., Reeve J., Einecke G., Sis B., Hidalgo L. G., Famulski K., Matas A., Halloran P. F., Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. American Journal of Transplantation 2012 12 2 388 399 2-s2.0-84856411838 10.1111/j.1600-6143.2011.03840.x
45. Naesens M., Kuypers D. R., de Vusser K., Vanrenterghem Y., Evenepoel P., Claes K., Bammens B., Meijers B., Lerut E., Chronic histological damage in early indication biopsies is an independent risk factor for late renal allograft failure. American Journal of Transplantation 2013 13 1 86 99 2-s2.0-84871716526 10.1111/j.1600-6143.2012.04304.x
46. Nankivell B. J., Borrows R. J., Fung C. L.-S., O'Connell P. J., Allen R. D. M., Chapman J. R., The natural history of chronic allograft nephropathy. The New England Journal of Medicine 2003 349 24 2326 2333 2-s2.0-0344666767 10.1056/NEJMoa020009 (Pubitemid 37509740)
47. Nankivell B. J., Borrows R. J., Fung C. L.-S., O'Connell P. J., Allen R. D. M., Chapman J. R., Natural history, risk factors, and impact of subclinical rejection in kidney transplantation. Transplantation 2004 78 2 242 249 2-s2.0-3943050053
48. Heilman R. L., Devarapalli Y., Chakkera H. A., Mekeel K. L., Moss A. A., Mulligan D. C., Mazur M. J., Hamawi K., Williams J. W., Reddy K. S., Impact of subclinical inflammation on the development of interstitial fibrosis and tubular atrophy in kidney transplant recipients. American Journal of Transplantation 2010 10 3 563 570 2-s2.0-76949097789 10.1111/j.1600-6143.2009.02966.x
49. Choi B. S., Shin M. J., Shin S. J., Kim Y. S., Choi Y. J., Kim Y.-S., Moon I. S., Kim S. Y., Koh Y. B., Bang B. K., Yang C. W., Clinical significance of an early protocol biopsy in living-donor renal transplantation: ten-year experience at a single center. American Journal of Transplantation 2005 5 6 1354 1360 2-s2.0-20544476880 10.1111/j.1600-6143.2005.00830.x (Pubitemid 40839425)
50. Moreso F., Ibernon M., Goma M., Carrera M., Fulladosa X., Hueso M., Gil-Vernet S., Cruzado J. M., Torras J., Grinyó J. M., Serón D., Subclinical rejection associated with chronic allograft nephropathy in protocol biopsies as a risk factor for late graft loss. American Journal of Transplantation 2006 6 4 747 752 2-s2.0-33644784069 10.1111/j.1600-6143.2005. 01230.x (Pubitemid 43345012)
51. Mannon R. B., Matas A. J., Grande J., Leduc R., Connett J., Kasiske B., Cecka J. M., Gaston R. S., Cosio F., Gourishankar S., Halloran P. F., Hunsicker L., Rush D., Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure. American Journal of Transplantation 2010 10 9 2066 2073 2-s2.0-77956160622 10.1111/j.1600-6143.2010. 03240.x
52. Gago M., Cornell L. D., Kremers W. K., Stegall M. D., Cosio F. G., Kidney allograft inflammation and fibrosis, causes and consequences. American Journal of Transplantation 2012 12 5 1199 1207 2-s2.0-84860496691 10.1111/j.1600-6143. 2011.03911.x
53. Moreso F., Carrera M., Goma M., Hueso M., Sellares J., Martorell J., Grinyó J. M., Serón D., Early subclinical rejection as a risk factor for late chronic humoral rejection. Transplantation 2012 93 1 41 46 2-s2.0-84655163829 10.1097/TP.0b013e31823bb647
54. Wiebe C., Gibson I. W., Blydt-Hansen T. D., Karpinski M., Ho J., Storsley L. J., Goldberg A., Birk P. E., Rush D. N., Nickerson P. W., Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant. American Journal of Transplantation 2012 12 5 1157 1167 2-s2.0-84860473178 10.1111/j.1600-6143.2012.04013.x
55. El Ters M., Grande J. P., Keddis M. T., Rodrigo E., Chopra B., Dean P. G., Stegall M. D., Cosio F. G., Kidney allograft survival after acute rejection, the value of follow-up biopsies. American Journal of Transplantation 2013 13 9 2334 2341 2-s2.0-84883456555 10.1111/ajt.12370
56. Rush D., Nickerson P., Gough J., McKenna R., Grimm P., Cheang M., Trpkov K., Solez K., Jeffery J., Beneficial effects of treatment of early subclinical rejection: a randomized study. Journal of the American Society of Nephrology 1998 9 11 2129 2134 2-s2.0-0031758130 (Pubitemid 28482163)
57. Kurtkoti J., Sakhuja V., Sud K., Minz M., Nada R., Kohli H. S., Gupta K. L., Joshi K., Jha V., The utility of 1- and 3-month protocol biopsies on renal allograft function: a randomized controlled study. American Journal of Transplantation 2008 8 2 317 323 2-s2.0-38149017862 10.1111/j.1600-6143.2007. 02049.x
58. Rush D., Arlen D., Boucher A., Busque S., Cockfield S. M., Girardin C., Knoll G., Lachance J.-G., Landsberg D., Shapiro J., Shoker A., Yilmaz S., Lack of benefit of early protocol biopsies in renal transplant patients receiving TAC and MMF: a randomized study. American Journal of Transplantation 2007 7 11 2538 2545 2-s2.0-35248889377 10.1111/j.1600-6143.2007.01979.x (Pubitemid 47561621)
59. Moreso F., Seron D., Carrera M., Gil-Vernet S., Cruzado J. M., Hueso M., Fulladosa X., Ramos R., Ibernon M., Castelao A. M., Grinyó J. M., Baseline immunosuppression is associated with histological findings in early protocol biopsies. Transplantation 2004 78 7 1064 1068 2-s2.0-6344247458 10.1097/01.TP.0000137268.85155.11 (Pubitemid 39391871)
60. Rowshani A. T., Scholten E. M., Bemelman F., Eikmans M., Idu M., Van Groningen M. C. R., Surachno J. S., Mallat M. J. K., Paul L. C., De Fijter J. W., Bajema I. M., Ten Berge I., Florquin S., No difference in degree of interstitial sirius red-stained area in serial biopsies from area under concentration-over-time curves-guided cyclosporine versus tacrolimus-treated renal transplant recipients at one year. Journal of the American Society of Nephrology 2006 17 1 305 312 2-s2.0-33645451698 10.1681/ASN.2005030249
61. Dean P. G., Grande J. P., Sethi S., Park W. D., Griffin M. D., Cosio F. G., Larson T. S., Stegall M. D., Kidney transplant histology after one year of continuous therapy with sirolimus compared with tacrolimus. Transplantation 2008 85 8 1212 1215 2-s2.0-42549102730 10.1097/TP.0b013e31816a8ae6 (Pubitemid 351590201)
62. Seron D., O'Valle F., Moreso F., Gomà M., Hueso M., Grinyó J. M., Del Moral R. G., Immunophenotype of infiltrating cells in protocol renal allograft biopsies from tacrolimus-versus cyclosporine-treated patients. Transplantation 2007 83 5 649 652 2-s2.0-33947315099 10.1097/01.tp.0000253760. 35580.d3 (Pubitemid 46440257)
63. Kumar M. S. A., Saeed M. I., Ranganna K., Malat G., Sustento-Reodica N., Kumar A. M. S., Meyers W. C., Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes. Transplant Immunology 2008 20 1-2 32 42 2-s2.0-56049095966 10.1016/j.trim.2008.08.005
64. Vitko S., Margreiter R., Weimar W., Three-year efficacy and safety results from a study of everolimus versus mycophenolate mofetil in de novo renal transplant patients. American Journal of Transplantation 2005 5 10 2521 2530
65. Mota A., Arias M., Taskinen E. I., Paavonen T., Brault Y., Legendre C., Claesson K., Castagneto M., Campistol J. M., Hutchison B., Burke J. T., Yilmaz S., Häyry P., Neylan J. F., Sirolimus-based therapy following early cyclosporine withdrawal provides significantly improved renal histology and function at 3 years. American Journal of Transplantation 2004 4 6 953 961 2-s2.0-2942534405 10.1111/j.1600-6143.2004.00446.x (Pubitemid 38745595)
66. Servais A., Meas-Yedid V., Toupance O., Lebranchu Y., Thierry A., Moulin B., Etienne I., Presne C., Hurault D. L. B., le Pogamp P., Le Meur Y., Glotz D., Hayem C., Marin J. C. O., Thervet E., Interstitial fibrosis quantification in renal transplant recipients randomized to continue cyclosporine or convert to sirolimus. American Journal of Transplantation 2009 9 11 2552 2560 2-s2.0-70350126186 10.1111/j.1600-6143.2009.02803.x
67. Lebranchu Y., Thierry A., Thervet E., Büchler M., Etienne I., Westeel P. F., De Ligny B. H., Moulin B., Rérolle J. P., Frouget T., Girardot-Seguin S., Toupance O., Efficacy and safety of early cyclosporine conversion to sirolimus with continued MMF-four-year results of the postconcept study. American Journal of Transplantation 2011 11 8 1665 1675 2-s2.0-79961039264 10.1111/j.1600-6143.2011.03637.x
68. Liefeldt L., Brakemeier S., Glander P., Waiser J., Lachmann N., Schönemann C., Zukunft B., Illigens P., Schmidt D., Wu K., Rudolph B., Neumayer H.-H., Budde K., Donor-specific HLA antibodies in a cohort comparing everolimus with cyclosporine after kidney transplantation. American Journal of Transplantation 2012 12 5 1192 1198 2-s2.0-84860431997 10.1111/j.1600-6143.2011. 03961.x
69. Stegall M. D., Park W. D., Larson T. S., Gloor J. M., Cornell L. D., Sethi S., Dean P. G., Prieto M., Amer H., Textor S., Schwab T., Cosio F. G., The histology of solitary renal allografts at 1 and 5 years after transplantation. American Journal of Transplantation 2011 11 4 698 707 2-s2.0-79953240917 10.1111/j.1600-6143.2010.03312.x
70. Naesens M., Lerut E., Damme B. V., Vanrenterghem Y., Kuypers D. R., Tacrolimus exposure and evolution of renal allograft histology in the first year after transplantation. American Journal of Transplantation 2007 7 9 2114 2123 2-s2.0-34547842740 10.1111/j.1600-6143.2007.01892.x (Pubitemid 47247039)
71. Chisholm-Burns M. A., Spivey C. A., Rehfeld R., Zawaideh M., Roe D. J., Gruessner R., Immunosuppressant therapy adherence and graft failure among pediatric renal transplant recipients. American Journal of Transplantation 2009 9 11 2497 2504 2-s2.0-70350126190 10.1111/j.1600-6143.2009.02793.x
72. Chisholm-Burns M. A., Spivey C. A., Zivin J. G., Lee J. K., Sredzinski E., Tolley E. A., Improving outcomes of renal transplant recipients with behavioral adherence contracts: a randomized controlled trial. American Journal of Transplantation 2013 13 9 2364 2373 2-s2.0-84883452621 10.1111/ajt.12341